Clinical Trials Browser

Phase 1 × Urinary Bladder Neoplasms × tislelizumab × Clear all

NCT07119996 2025-08-13

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

Phase 1 Not yet recruiting

Urinary Bladder Neoplasms, Neoplasms